Chinese Patent issued for LuerJack
On the 14th of February 2017, the Chinese Patent and Trademark office issued an official document granting the Chinese patent for LuerJack. ConceptoMed’s strategy to protect our intellectual property rights (IPR) remains unchanged and strong. Along with other markets already protected, such as Europe, the US, Australia and Mexico, protection in Asia is now following.
European and Australian Patent Issued for Luer-Jack
On the 31st of August 2016, the European Patent Office issued an official document granting the European patent for Luer-Jack. IP Australia, the Australian Government agency that administers intellectual property (IP) rights and legislation relating to patents, issued an official document granting the Australian patent for Luer-Jack - also on the 31st of August 2016.
US Patent issued for Luer-Jack®
On the 10th of May 2016, the United States Patent and Trademark office issued an official document granting the US patent for Luer-Jack. The US Luer-Jack patent is an important part of the families of similar filed applications in all important markets world wide, and is a fundamental member of the Luer-Jack patent family.
The Norwegian Minister of Health Bent Høie visits ConceptoMed at its Headquarters – the new syringe technology Luer-Jack® - 2nd of June 2015
The Norwegian Minister of Health Bent Høie will see how medical equipment in a simple and efficient way can increase quality for a large number of medical procedures. ConceptoMed is moving front stage to initiate and elevate focus on quality during the billions of small procedures being executed worldwide.
Oversubscribed Private Placement of €1.42 Million
The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. The share issue was oversubscribed and provided the company with 12 new shareholders. Gross proceeds from the private placement amounted to NOK 11,550,000 (€1.42 Million)